Insights

Rapid Protein Solutions Nuclera's eProtein Discovery system offers fast, multiplex protein screening and expression capabilities within days, making it highly attractive for research labs needing quick turnaround times for protein characterization, including challenging membrane proteins.

Strategic Collaborations Recent partnerships with Cytiva and leadXpro demonstrate Nuclera's focus on integrating advanced biophysical and AI/ML technologies, opening opportunities to offer comprehensive, end-to-end solutions to forward-thinking biotech and pharma companies.

Expanding Protein Portfolio The launch of new panels such as the nanodisc GPCRs and membrane protein workflows showcases Nuclera's product diversification, providing avenues to target research areas involving complex membrane protein studies for drug discovery and development.

Funding and Growth A recent Series C financing round of $87 million indicates strong investor confidence and financial stability, enabling Nuclera to accelerate product development, expand its sales efforts, and explore new market segments within biotech and academic research institutions.

Global Presence With operations in both Cambridge and Boston, Nuclera is well-positioned to tap into North American and European biotech clusters, providing increased opportunities to engage with innovative research labs and pharmaceutical companies seeking cutting-edge protein discovery solutions.

Nuclera Tech Stack

Nuclera uses 8 technology products and services including Salesforce, Oracle Database, Salesforce B2B Commerce, and more. Explore Nuclera's tech stack below.

  • Salesforce
    Customer Relationship Management
  • Oracle Database
    Database
  • Salesforce B2B Commerce
    E-commerce Platforms
  • Apple iCloud Mail
    Email
  • GitLab
    Issue Trackers
  • Web Vitals
    Javascript Libraries
  • ipify
    Mapping And Gis
  • Nginx
    Web Servers

Media & News

Nuclera's Email Address Formats

Nuclera uses at least 1 format(s):
Nuclera Email FormatsExamplePercentage
FLast@nuclera.comJDoe@nuclera.com
98%
FMiddleLast@nuclera.comJMichaelDoe@nuclera.com
1%
Last@nuclera.comDoe@nuclera.com
1%

Frequently Asked Questions

Where is Nuclera's headquarters located?

Minus sign iconPlus sign icon
Nuclera's main headquarters is located at Chivers Way Cambridge, England United Kingdom. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is Nuclera's official website and social media links?

Minus sign iconPlus sign icon
Nuclera's official website is nuclera.com and has social profiles on LinkedInCrunchbase.

What is Nuclera's SIC code NAICS code?

Minus sign iconPlus sign icon
Nuclera's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Nuclera have currently?

Minus sign iconPlus sign icon
As of February 2026, Nuclera has approximately 135 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Chief Commercial Officer (cco): J. B.Chief Financial Officer: S. B.Chief Information Security Officer: A. Z.. Explore Nuclera's employee directory with LeadIQ.

What industry does Nuclera belong to?

Minus sign iconPlus sign icon
Nuclera operates in the Biotechnology Research industry.

What technology does Nuclera use?

Minus sign iconPlus sign icon
Nuclera's tech stack includes SalesforceOracle DatabaseSalesforce B2B CommerceApple iCloud MailGitLabWeb VitalsipifyNginx.

What is Nuclera's email format?

Minus sign iconPlus sign icon
Nuclera's email format typically follows the pattern of FLast@nuclera.com. Find more Nuclera email formats with LeadIQ.

How much funding has Nuclera raised to date?

Minus sign iconPlus sign icon
As of February 2026, Nuclera has raised $43M in funding. The last funding round occurred on Feb 02, 2022 for $43M.

When was Nuclera founded?

Minus sign iconPlus sign icon
Nuclera was founded in 2013.

Nuclera

Biotechnology ResearchEngland, United Kingdom51-200 Employees

Nuclera exists to remove uncertainty from protein science. As the pioneer of multiplex protein screening, we help researchers start with clarity, so ideas move faster to result. We believe access to your protein should be a certainty, not a gamble. eProtein Discovery™ is how we deliver on that promise, but our aim is bigger: to make protein access routine for every lab, accelerate breakthroughs in human health, and empower scientists to spend more time on discovery and less on delay.

Our eProtein Discovery™ system combines unique cell free expression systems, novel digital microfluidics, and robust screening data, to create an effortlessly multiplex protein screening solution that empowers you to perform your own protein screening, characterization, and small-scale expression in-house within days — even challenging membrane proteins

Founded in 2013 by PhD students at the University of Cambridge, the company now has a presence in Cambridge, UK and Boston, MA employing over 100 employees.

Section iconCompany Overview

Headquarters
Chivers Way Cambridge, England United Kingdom
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
51-200

Section iconFunding & Financials

  • $43M

    Nuclera has raised a total of $43M of funding over 1 rounds. Their latest funding round was raised on Feb 02, 2022 in the amount of $43Mas a Series B.

  • $10M$25M

    Nuclera's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $43M

    Nuclera has raised a total of $43M of funding over 1 rounds. Their latest funding round was raised on Feb 02, 2022 in the amount of $43Mas a Series B.

  • $10M$25M

    Nuclera's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.